ViewMind Brings Scalable, Noninvasive Alzheimer’s Screening to Primary Care
StartUp Health community member Mark Edwards, CEO & Co-founder of ViewMind, shares how his team is advancing precision, scalable, and noninvasive screening for Alzheimer’s disease in primary care settings. He explains how current assessments are costly, invasive, and often out of reach, while ViewMind delivers accurate cognitive insights by measuring eye movements and pupillary responses within an extended reality headset. Their proprietary algorithms interpret complex data patterns to assess specific brain networks. Mark highlights early commercialization success across more than 20 concierge and longevity clinics, where ViewMind is used to measure cognition before, during, and after treatments. He also reflects on the role of the Alzheimer’s Health Moonshot Community in raising awareness and connecting them with mission-aligned partners.
